Journal of Dairy Science
Volume 89, Issue 6 , Pages 1877-1895 , June 2006

Invited Review: The Role of Cow, Pathogen, and Treatment Regimen in the Therapeutic Success of Bovine Staphylococcus aureus Mastitis

  • H.W. Barkema

      Affiliations

    • Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada
    • Corresponding Author InformationCorresponding author.
    • ,
  • Y.H. Schukken

      Affiliations

    • Quality Milk Production Services, Cornell University, Ithaca, NY 14850-1263
    • ,
  • R.N. Zadoks

      Affiliations

    • Quality Milk Production Services, Cornell University, Ithaca, NY 14850-1263

Received 31 October 2005 ,Accepted 1 January 2006.

References 

  1. Aarestrup FM, Dangler CA, Sordillo LM. Prevalence of coagulase gene polymorphism in Staphylococcus aureus isolates causing bovine mastitis. Can. J. Vet. Res. 1995;59:124–128
  2. Allore HG, Erb HN. Partial budget of the discounted annual benefit of mastitis control strategies. J. Dairy Sci. 1998;81:2280–2291
  3. Allore HG, Erb HN, Schruben LW, Oltenacu PA. A simulation of strategies to lower bulk tank somatic cell count below 500,000 per milliliter. J. Dairy Sci. 1998;81:694–702
  4. Alluwaimi AM. The cytokines of bovine mammary gland: Prospects for diagnosis and therapy. Res. Vet. Sci. 2004;77:211–222
  5. Barkema HW, Deluyker HA, Schukken YH, Lam TJGM. Quarter-milk somatic cell count at calving and at the first milking after calving. Prev. Vet. Med. 1999;38:1–9
  6. Barkema HW, Schukken YH, Lam TJ, Galligan DT, Beiboer ML, Brand A. Estimation of interdependence among quarters of the bovine udder with subclinical mastitis and implications for analysis. J. Dairy Sci. 1997;80:1592–1599
  7. Barkema HW, Schukken YH, Lam TJGM, Beiboer ML, Wilmink H, Benedictus G, et al. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 1998;81:411–419
  8. Barkema HW, Schukken YH, Lam TJGM, Beiboer ML, Benedictus G, Brand A. Management practices associated with low, medium, and high somatic cell counts in bulk milk. J. Dairy Sci. 1998;81:1917–1927
  9. Barlow J, Nightingale C, Zadoks R, White L, Schukken YH. Direct and indirect effects of subclinical mastitis treatment in dairy herds. In: Proc. 4th Int. Dairy Fed. Mastitis Seminar. Maastricht, The Netherlands. Wageningen Acad. Publ., Wageningen, The Netherlands. 2005;p. 321–326
  10. Borm AA, Fox LK, Leslie KE, Hogan JS, Andrew SM, Oliver SP, et al. Prepartum intramammary antibiotic therapy: Effects on udder health, milk production, and reproductive performance in dairy heifers. In: Proc. 4th Int. Dairy Fed. Mastitis Seminar. Maastricht, The Netherlands. Wageningen Acad. Publ., Wageningen, The Netherlands. 2005;p. 364–369
  11. Broadbent JR, Chou YC, Gillies K, Kondo JK. Nisin inhibits several gram-positive, mastitis-causing pathogens. J. Dairy Sci. 1989;72:3342–3345
  12. Brouillette E, Martinez A, Boyll BJ, Allen NE, Malouin F. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol. Med. Microbiol. 2004;41:35–41
  13. Buelow KL, Thomas CB, Goodger WJ, Nordlund KV, Collins MT. Effect of milk sample collection strategy on sensitivity and specificity of bacteriologic culture and somatic cell count for detection of Staphylococcus aureus intramammary infection in dairy cattle. Prev. Vet. Med. 1996;26:1–8
  14. Constable PD, Morin DE. Treatment of clinical mastitis: Using antimicrobial susceptibility profiles for treatment decisions. Vet. Clin. North Am. Food Anim. Pract. 2003;19:139–155
  15. Costa EO, Benites NR, Guerra JL, Melvilla PA. Antimicrobial susceptibility of Staphylococcus aureus spp. isolated from mammary parenchymas of slaughtered dairy cows. J. Vet. Med. B. 2000;47:99–103
  16. Coughlin R, Tikofsky L, Schulte H, Bennett G, Rejman J, Fisher D, et al. Lactation therapy with the nisin-based product MastOut: Results of a 125-cow study. In: Proc. 43rd Ann. Mtg. Natl. Mastitis Counc., Charlotte, NC. Natl. Mastitis Counc., Madison, WI. 2004;p. 296–297
  17. Craven N. Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation – A review. Br. Vet. J. 1987;143:410–422
  18. Cucarella C, Tormo MA, Ubeda C, Trotonda MP, Monzon M, Peris C, et al. Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus. Infect. Immun. 2004;72:2177–2185
  19. DeGraves FJ, Fetrow J. Economics of mastitis and mastitis control. Vet. Clin. North Am. Food Anim. Pract. 1993;9:421–434
  20. Deluyker HA, Chester ST, Van Oye SN. A multilocation clinical trial in lactating dairy cows affected with clinical mastitis to compare the efficacy of treatment with intramammary infusions of a lincomycin/neomycin combination with an ampicillin/cloxacillin combination. J. Vet. Pharmacol. Ther. 1999;22:274–282
  21. Deluyker HA, Van Oye SN, Boucher JF. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J. Dairy Sci. 2005;88:604–614
  22. De Oliveira AP, Watts JL, Salmon SL, Aarestrup FM. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and the United States. J. Dairy Sci. 2000;83:855–862
  23. Diarra MS, Petitclerc D, Lacasse P. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 2002;85:1141–1149
  24. Dingwell RT, Leslie KE, Duffield TF, Schukken YH, DesCoteaux L, Keefe GP, et al. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. J. Dairy Sci. 2003;86:159–168
  25. Dingwell RT, Leslie KE, Pacan J, Lepp D, Sabour P. The influence of the pulsed-field gel electrophoresis molecular type of subclinical Staphylococcus aureus on dry period elimination in Canadian dairy herds. In: Proc. 43rd Ann. Mtg. Natl. Mastitis Counc.. Charlotte, NC. Natl. Mastitis Counc., Madison, WI. 2004;
  26. Edmondson PW. An economic justification of “blitz” therapy to eradicate Streptococcus agalactiae from a dairy herd. Vet. Rec. 1989;125:591–593
  27. Edmondson PW. Clinical mastitis in dairy cows after ‘blitz’ therapy. Vet. Rec. 1997;141:108
  28. Enright MC, Spratt BG. Multilocus sequence typing. Trends Microbiol. 1999;7:482–487
  29. Erskine RJ. Antimicrobial drug use in bovine mastitis. In:  Prescott JF,  Baggot JD,  Walker RD editor. Antimicrobial Therapy in Veterinary Medicine. 3rd ed.. Ames IA: Blackwell Publishing; 2000;p. 712–734
  30. Erskine, R. J., J. Cullor, M. Schaellibaum, R. Yancey, and A. Zecconi. 2004. Bovine mastitis pathogens and trends in resistance to antimicrobial drugs. National Mastitis Council. http://www.nmconline.org/docs/ResPaper.pdf Accessed Mar. 28, 2006.
  31. Erskine RJ, Eberhart RJ. Comparison of duplicate and single quarter milk samples for the identification of intramammary infections. J. Dairy Sci. 1988;71:854–856
  32. Erskine RJ, Wagner SA, DeGraves FJ. Mastitis therapy and pharmacology. Vet. Clin. North Am. Food Anim. Pract. 2003;19:109–138
  33. Erskine RJ, Walker RD, Bolin CA, Bartlett PC, White DG. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 2002;85:1111–1118
  34. Fox LK, Zadoks RN, Gaskins CT. Biofilm production by Staphylococcus aureus associated with intramammary infection. Vet. Microbiol. 2005;107:295–299
  35. Friton GM, Sobiraj A, Richter A. Effects of various antibiotic treatments of lactating cows with subclinical mastitis. Tierarzl. Prax. Ausg. G Grosstiere Nutztiere. 1998;26:254–260
  36. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 2005;187:2426–2438
  37. Gillespie BE, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC, et al. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp. and Staphylococcus aureus intramammary infections in lactating dairy cows. Vet. Ther. 2002;3:373–380
  38. Godden SM, Jansen JT, Leslie KE, Smart NL, Kelton DF. The effect of sampling time and sample handling on the detection of Staphylococcus aureus in milk from quarters with subclinical mastitis. Can. Vet. J. 2002;43:38–42
  39. Goodger WJ, Ferguson G. Benefits and costs of a control program for an epizootic of Staphylococcus aureus mastitis. J. Am. Vet. Med. Assoc. 1987;190:1284–1287
  40. Guidry A, Fattom A, Pattel A, O’Brien C, Shepherd S, Lohuis J. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am. J. Vet. Res. 1998;59:1537–1539
  41. Guterbock WM, Van Eenennaam AL, Anderson RJ, Gardner IA, Cullor JS, Holmberg CA. Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens. J. Dairy Sci. 1993;76:3437–3444
  42. Haveri M, Suominen S, Rantala L, Honkanen-Buzalski T, Pyörälä S. Comparison of phenotypic and genotypic detection of penicillin G resistance of Staphylococcus aureus isolated from bovine intramammary infection. Vet. Microbiol. 2005;106:97–102
  43. Haveri M, Taponen S, Vuopio-Varkila J, Salmenlinna S, Pyörälä S. Bacterial genotype affects the manifestation and persistence of bovine Staphylococcus aureus intramammary infection. J. Clin. Microbiol. 2005;43:959–961
  44. Hensen, S. M. 2000. Bovine Staphylococcus aureus mastitis – bacterial adhesion and invasion in relation to pathogenesis and antimicrobial sensitivity. PhD Thesis, Utrecht University, The Netherlands.
  45. Hensen SM, Pavicic MJ, Lohuis JA, Poutrel B. Use of bovine primary mammary epithelial cells for the comparison of adherence and invasion ability of Staphylococcus aureus strains. J. Dairy Sci. 2000;83:418–429
  46. Hillerton JE, Bramley AJ, Staker RT, McKinnon CH. Patterns of intramammary infection and clinical mastitis over a 5 year period in a closely monitored herd applying mastitis control measures. J. Dairy Res. 1995;62:39–50
  47. Hillerton JE, Kliem KE. Effective treatments of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J. Dairy Sci. 2002;85:1009–1014
  48. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, et al. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA. 2004;101:9786–9791
  49. Houben FH, Huirne RB, Dijkhuizen AA, Kristensen AR. Optimal replacement of mastitic cows determined by a hierarchic Markov process. J. Dairy Sci. 1994;77:2975–2993
  50. Hu S, Concha C, Johannisson A, Meglia G, Waller KP. Effect of subcutaneous injection of ginseng on cows with subclinical Staphylococcus aureus mastitis. J. Vet. Med. B. Infect. Dis. Public Health. 2001;48:519–528
  51. Hwang CY, Pak SI, Han HR. Effects of autogenous toxoid-bacterin in lactating cows with Staphylococcus aureus subclinical mastitis. J. Vet. Med. Sci. 2000;62:875–880
  52. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: Genomic island SCC. Drug Resist. Updat. 2003;6:41–52
  53. Janosi S, Huszenicza A, Horvath T, Gemes F, Kulcsar M, Huszenicza G. Bacteriological recovery after intramuscular or intracisternal spiramycin-based drying-off therapy. Acta Vet. Hung. 2001;49:155–162
  54. Karreman HJ. Treating dairy cows naturally: Thoughts and strategies. Paradise, PA: Paradise Publications; 2004;
  55. Kerro Dogo O, van Dijk JE, Nederbragt H. Factors involved in the early pathogenesis of bovine Staphylococcus aureus mastitis with emphasis on bacterial adhesion and invasion. A review. Vet. Q. 2002;24:181–198
  56. Lam TJGM, de Jong MCM, Schukken YH, Brand A. Mathematical modeling to estimate efficacy of postmilking teat disinfection in split-udder trials of dairy cows. J. Dairy Sci. 1996;79:62–70
  57. Lam TJGM, van Wuijckhuise LA, Franken P, Morselt ML, Hartman EG, Schukken YH. Use of composite milk samples for diagnosis of Staphylococcus aureus mastitis in dairy cattle. J. Am. Vet. Med. Assoc. 1996;208:1705–1708
  58. Lammers, A. 2000. Pathogenesis of Staphylococcus aureus mastitis. In vitro studies on adhesion, invasion and gene expression. PhD Thesis, Utrecht University, The Netherlands.
  59. Lammers A, Nuijten PJ, Smith HE. The fibronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary gland cells. FEMS Microbiol. Lett. 1999;180:103–109
  60. Loeffler SH, Lam TJGM, Barkema HW, Scholten D, Hessels AL, van Gestel AM. The dairying veterinary approach to a high bulk milk cell count caused by Streptococcus agalactiae. Tijdschr. Diergeneeskd. 1995;120:458–463
  61. Lohuis JACM, Hensen SM, Beers H. MIC's and combined activity of penicillin and neomycin against Staphylococcus aureus strains from bovine mastitis as determined by microdilution and checkerboard assay. In: Proc. 3rd Int. Mastitis Seminar. Tel Aviv, Israel, Session 5. 1995;p. 114–115
  62. Luby CD, Middleton JR. Efficacy of vaccination and antibiotic therapy against Staphylococcus aureus mastitis in dairy cattle. Vet. Rec. 2005;157:89–90
  63. Makovec JA, Ruegg PL. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994–2001). J. Am. Vet. Med. Assoc. 2003;222:1582–1589
  64. Middleton JR, Fox LK. Influence of Staphylococcus aureus strain on mammary quarter milk production. In: Proc. 39th Annu. Mtg.. Natl. Mastitis Counc., Atlanta, GA. Natl. Mastitis Counc., Madison, WI. 2001;p. 179–180
  65. Mullarky IK, Su C, Frieze N, Park YH, Sordillo LM. Staphylococcus aureus agr genotypes with enterotoxin production capabilities can resist neutrophil bactericidal activity. Infect. Immun. 2001;69:45–51
  66. Myllys V, Aplund K, Brofeld E, Horvila-Koski V, Honkanen-Buzalski T, Junttila J, et al. Bovine mastitis in Finland in 1988 and 1995 – Changes in prevalence and antimicrobial resistance. Acta Vet. Scand. 1998;39:119–126
  67. National Mastitis Council. 2001. National Mastitis Council Recommended Mastitis Control Program. http://www.nmconline.org/docs/NMC10steps.pdf Accessed Mar. 28, 2006.
  68. Neave FK, Dodd FH, Kingwill RG, Westgarth DR. Control of mastitis in the dairy herd by hygiene and management. J. Dairy Sci. 1969;52:696–707
  69. Nickerson SC, Owens WE, Boddie RL. Mastitis in dairy heifers: Initial studies on prevalence and control. J. Dairy Sci. 1995;78:1607–1618
  70. Oliver SP, Gillespie BE, Ivey SJ, Lewis MJ, Johnson DL, Lamar KC, et al. Influence of prepartum pirlimycin hydrochloride or penicillin-novobiocin therapy on mastitis in heifers during early lactation. J. Dairy Sci. 2004;87:1727–1731
  71. Oliver SP, Lewis MJ, Gillespie BE, Dowlen HH. Influence of prepartum antibiotic therapy on intramammary infections in primigravid heifers during early lactation. J. Dairy Sci. 1992;75:406–414
  72. Oliver SP, Lewis MJ, Gillespie BE, Dowlen HH, Jaenicke EC, Roberts RK. Prepartum antibiotic treatment of heifers: Milk production, milk quality and economic benefit. J. Dairy Sci. 2003;86:1187–1193
  73. Osteras O, Edge VL, Martin SW. Determinants of success or failure in the elimination of major mastitis pathogens in selective dry cow therapy. J. Dairy Sci. 1999;82:1221–1231
  74. Owens WE, Nickerson SC. Morphologic study of Staphylococcus aureus L-form, reverting, and intermediate colonies in situ. J. Clin. Microbiol. 1989;27:1382–1386
  75. Owens WE, Nickerson SC, Boddie RL, Tomita GM, Ray CH. Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy. J. Dairy Sci. 2001;84:814–817
  76. Owens WE, Ray CH. Therapeutic and prophylactic effect of prepartum antibiotic infusion in heifers. Zentralbl. Veterinarmed. B. 1996;43:455–459
  77. Owens WE, Ray CH, Boddie RL, Nickerson SC. Antibiotic treatment of mastitis: Comparison of intramammary and intramammary plus intramuscular therapies. J. Dairy Sci. 1988;71:3143–3147
  78. Owens WE, Ray CH, Boddie RL, Nickerson SC. Efficacy of sequential intramammary antibiotic treatment against chronic Staphylococcus aureus intramammary infection. Large Anim. Pract. 1997;18:10–14
  79. Persson Waller K, Gronlund U, Johannisson A. Intramammary infusion of beta 1,3-glucan for prevention and treatment of Staphylococcus aureus mastitis. J. Vet. Med. B Infect. Dis. Vet. Public Health. 2003;50:121–127
  80. Poelarends JJ, Hogeveen H, Sampimon OC, Sol J. Monitoring subclinical mastitis in Dutch dairy herds. In: Proc. 2nd Int. Symp. Mastitis and Milk Quality, Vancouver, BC, Canada. Madison, WI: National Mastitis Counc.; 2001;p. 145–149
  81. Pyörälä S. Letter to the Editor: Concerning an article comparing the efficacy of local and systemic treatment of clinical mastitis. J. Dairy Sci. 2005;88:1617
  82. Pyörälä SH, Pyörälä EO. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989–1995). J. Am. Vet. Med. Assoc. 1998;212:407–412
  83. Remmen JWA, van de Laar JMJ, Jaartsveld FHJ. The effect of treatment with Nafpenzal MC of all cows with subclinical mastitis in 15 dairy herds. In: Proc. 12th World Congr. Dis. Cattle, Amsterdam, The Netherlands. World Assoc. Buiatrics, Toulouse, France. 1982;p. 1059
  84. Roberson JR. Establishing treatment protocols for clinical mastitis. Vet. Clin. North Am. Food Anim. Pract. 2003;19:223–234
  85. Sampimon OC, Sol J. Efficacy of a cloxacillin dry cow product for treatment of heifers on farms with a low and a high prevalence of heifer mastitis in The Netherlands. In: Proc. 4th Int. Dairy Fed. Mastitis Seminar, Maastricht, The Netherlands. Int. Dairy Fed., Brussels, Belgium.. 2005;p. 278–284
  86. Sandholm M. A critical view on antibacterial mastitis therapy. In:  Sandholm M,  Honkanen-Buzalski T,  Kaartinen L,  Pyörälä S editor. The bovine udder and mastitis. Javäskylä, Finland: Gummerus Press; 1995;p. 169–186
  87. Schällibaum M, Nicolet J, Bosson J. Treatment of chronic subclinical staphylococcal mastitis in lactating cows by administrating high doses of spiramycin. Schweiz. Arch. Tierheilkd. 1981;123:277–292[In German]
  88. Schukken YH, Deluyker HA. Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitis. J. Vet. Pharmacol. Ther. 1995;18:274–283
  89. Schukken YH, Gröhn YT, McDermott B, McDermott JJ. Analysis of correlated discrete observations: Background, examples and solutions. Prev. Vet. Med. 2003;59:223–240
  90. Schukken YH, Wilson DJ, Welcome F, Garrison-Tikofsky L, Gonzalez RN. Monitoring udder health and milk quality using somatic cell counts. Vet. Res. 2003;34:579–596
  91. Sears P. Staphylococcal vaccines: What are the new strategies?. In: Proc. 41st Ann. Mtg. Natl. Mastitis Counc.. Orlando, Florida. Natl. Mastitis Counc. Inc., Madison, WI. 2002;p. 86–92
  92. Sears PM, Belschner AP. Alternative management and economic considerations in Staphylococcus aureus elimination programs. In: Proc. 38th Ann. Mtg. Natl. Mastitis Counc.. Arlington, VA. Natl. Mastitis Counc. Inc., Madison, WI. 1999;p. 86–92
  93. Sears PM, McCarthy KK. Management and treatment of staphylococcal mastitis. Vet. Clin. North Am. Food Anim. Pract. 2003;19:171–185
  94. Sears PM, Smith BS, English PB, Herer PS, Gonzalez RN. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. J. Dairy Sci. 1990;72:1900–1906
  95. Sears PM, Wilson DJ, Gonzalez RN, Hancock DD. Microbiological results from milk samples obtained premilking and postmilking for the diagnosis of bovine intramammary infections. J. Dairy Sci. 1991;74:4183–4188
  96. Seegers, H., C. Fourichon, D. Billon, and P. Hortet. 2004. Cost-benefit analysis of mastitis control by simulation: Model description and profitability of strategies targeting subclinically infected cows. Pages 179–186 in Proc. Soc. Vet. Epidemiol. Prev. Med., Martigny, Switzerland. Soc. Vet. Epidemiol. Prev. Med., www.svepm.org.uk
  97. Sérieys F, Raguet Y, Goby L, Schmidt H, Friton G. Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J. Dairy Sci. 2005;88:93–99
  98. Shephard RW, Malmo J, Pfeiffer DU. A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk. Aust. Vet. J. 2000;78:763–768
  99. Shephard RW, Burman S, Marcun P. A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows. Aust. Vet. J. 2004;82:624–629
  100. Smith TH, Fox LK, Middleton JR. Outbreak of mastitis caused by one strain of Staphylococcus aureus in a closed dairy herd. J. Am. Vet. Med. Assoc. 1998;212:553–556
  101. Smith EM, Green LE, Medley GF, Bird HE, Fox LK, Schukken YH, et al. Multilocus sequence typing of intercontinental bovine Staphylococcus aureus isolates. J. Clin. Microbiol. 2005;43:4737–4743
  102. Sol J, Sampimon OC, Barkema HW, Schukken YH. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 2000;83:278–284
  103. Sol J, Sampimon OC, Hartman E, Barkema HW. Effect of preculture freezing and incubation on bacteriological isolation from subclinical mastitis samples. Vet. Microbiol. 2002;85:241–249
  104. Sol J, Sampimon OC, Snoep JJ, Schukken YH. Factors associated with bacteriological cure after dry cow treatment of subclinical Staphylococcus aureus mastitis with antibiotics. J. Dairy Sci. 1994;77:75–79
  105. Sol J, Sampimon OC, Snoep JJ, Schukken YH. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 1997;80:2803–2808
  106. Sordillo LM, Nickerson SC, Akers RM. Pathology of Staphylococcus aureus mastitis during lactogenesis: Relationships with bovine mammary structure and function. J. Dairy Sci. 1989;72:228–240
  107. St. Rose SG, Swinkels JM, Kremer WD, Kruitwagen CL, Zadoks RN. Effect of penethamate hydriodide treatment on bacteriological cure, somatic cell count and milk production of cows and quarters with chronic subclinical Streptococcus uberis or Streptococcus dysgalactiae infection. J. Dairy Res. 2003;70:387–394
  108. Struelens MJ, De Gheldre Y, Deplano A. Comparative and library epidemiological typing systems: Outbreak investigations versus surveillance systems. Infect. Control Hosp. Epidemiol. 1998;19:565–569
  109. Swinkels JM, Rooijendijk RG, Hogeveen H, Zadoks RN. Economic benefits of lactational treatment of subclinical Staphylococcus aureus mastitis. J. Dairy Sci. 2005;88:4273–4287
  110. Takahashi H, Komatsu T, Hodate K, Horino R, Yokomizo Y. Effect of intramammary injection of RbIL-8 on milk levels of somatic cell count, chemiluminescence activity and shedding patterns of total bacteria and Staph. aureus in Holstein cows with naturally infected subclinical mastitis. J. Vet. Med. B Infect. Dis. Vet. Public Health. 2005;52:32–37
  111. Taponen S, Dredge K, Henriksson B, Pyyhtia AM, Suojala L, Junni R, et al. Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin G plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria—A double blind field study. J. Vet. Pharmacol. Ther. 2003;26:193–198
  112. Taponen S, Jantunen A, Pyörälä E, Pyörälä S. Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus. Acta Vet. Scand. 2003;44:53–62
  113. Thorburn MA. General principles for the design of clinical trials with special reference to mastitis therapy. IDF Bull. 1990;247:39–48
  114. Tikofsky LL, Barlow JW, Santisteban C, Schukken YH. A comparison of antimicrobial susceptibility patterns for Staphylococcus aureus in organic and conventional dairy herds. Microb. Drug Resist. 2003;9(Suppl. 1):S39–S45
  115. Tikofsky LL, Zadoks RN. An alternative treatment trial for Staphylococcus aureus mastitis in organically managed dairy cattle. In: Proc. 4th Int. Dairy Fed. Mastitis Seminar. Maastricht, The Netherlands. Int. Dairy Fed., Brussels, Belgium. 2005;p. 358–363
  116. Timms LL. Evaluation of pirlimycin for blitz therapy of chronic Staphylococcus aureus mastitis in dairy cows. In: Proc. 34th Annu. Mtg Natl. Mastitis Counc.. Fort Worth, TX. Natl. Mastitis Counc. Inc., Madison, WI. 1995;p. 140–141
  117. Timms LL, Kirkpatrick M, Sears P. Field trial evaluation of extended pirlimycin therapy with or without vaccination for Staphylococcus aureus mastitis. In: Proc. 39th Annu. Mtg. Natl. Mastitis Counc.. Atlanta, GA. Natl. Mastitis Counc., Inc., Madison, WI. 2000;p. 201–202
  118. Ubeda C, Maiques E, Knecht E, Lasa I, Novick RP, Penades JR. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol. Microbiol. 2005;56:836–844
  119. Ubeda C, Tormo MA, Cucarella C, Trotonda P, Foster TJ, Lasa I, et al. Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol. Microbiol. 2003;49:193–210
  120. Van Eenennaam AL, Gardner IA, Holmes J, Perani L, Anderson RJ, Cullor JS, et al. Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. J. Dairy Sci. 1995;78:2086–2095
  121. Vasudevan P, Nair MK, Annamalai T, Venkitanarayanan KS. Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Vet. Microbiol. 2003;92:179–185
  122. Wilson DJ, Gonzalez RN, Case KL, Garrison LL, Gröhn YT. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J. Dairy Sci. 1999;82:1664–1670
  123. Wilson DJ, Gonzalez RN, Sears PM. Segregation or use of separate milking units for cows infected with Staphylococcus aureus: Effects on prevalence of infection and bulk tank somatic cell count. J. Dairy Sci. 1995;78:2083–2085
  124. Wraight MD. A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms. N.Z. Vet. J. 2003;51:26–32
  125. Yamagata M, Goodger WJ, Weaver L, Franti C. The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows. J. Am. Vet. Med. Assoc. 1987;191:1556–1561
  126. Yancey RJ, Sanchez MS, Ford CW. Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils. Eur. J. Clin. Microbiol. Infect. Dis. 1991;10:107–113
  127. Zadoks RN, Allore HG, Barkema HW, Sampimon OC, Wellenberg GJ, Gröhn YT, et al. Cow- and quarter-level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. J. Dairy Sci. 2001;84:2649–2663
  128. Zadoks RN, Allore HG, Hagenaars TJ, Barkema HW, Schukken YH. A mathematical model of Staphylococcus aureus control in dairy herds. Epidemiol. Infect. 2002;129:397–416
  129. Zadoks RN, van Leeuwen WB, Barkema HW, Sampimon OC, Verbrugh H, Schukken YH, et al. Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiology of bovine and human Staphylococcus aureus. J. Clin. Microbiol. 2000;38:1931–1939
  130. Zadoks RN, Van Leeuwen WB, Kreft D, Fox LK, Barkema HW, Schukken YH, et al. Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing. J. Clin. Microbiol. 2002;40:3894–3902
  131. Zecconi A, Piccinini R, Zepponi A, Ruffo G. Recovery of Staphylococcus aureus from centrifuged quarter milk samples. J. Dairy Sci. 1997;80:3058–3063
  132. Zepeda L, Buelow KL, Nordlund KV, Thomas CB, Collins MT, Goodger WJ. A linear programming assessment of the profit from strategies to reduce the prevalence of Staphylococcus aureus mastitis. Prev. Vet. Med. 1998;33:183–193
  133. Ziv G, Storper M. Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J. Vet. Pharmacol. Ther. 1985;8:276–283

PII: S0022-0302(06)72256-1

doi: 10.3168/jds.S0022-0302(06)72256-1

Journal of Dairy Science
Volume 89, Issue 6 , Pages 1877-1895 , June 2006

Article Tools

* Image Usage & Resolution